AU672810B2 - Hydroxamic acid derivatives and their use as anti-inflammatory compounds - Google Patents

Hydroxamic acid derivatives and their use as anti-inflammatory compounds Download PDF

Info

Publication number
AU672810B2
AU672810B2 AU47170/93A AU4717093A AU672810B2 AU 672810 B2 AU672810 B2 AU 672810B2 AU 47170/93 A AU47170/93 A AU 47170/93A AU 4717093 A AU4717093 A AU 4717093A AU 672810 B2 AU672810 B2 AU 672810B2
Authority
AU
Australia
Prior art keywords
methylprop
enyl
formula
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47170/93A
Other languages
English (en)
Other versions
AU4717093A (en
Inventor
David Evan Davies
Simon Teanby Hodgson
Steven Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU4717093A publication Critical patent/AU4717093A/en
Application granted granted Critical
Publication of AU672810B2 publication Critical patent/AU672810B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47170/93A 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds Ceased AU672810B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929215921A GB9215921D0 (en) 1992-07-27 1992-07-27 Anti-inflammatory compounds
GB9215921 1992-07-27
PCT/GB1993/001585 WO1994002448A1 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
AU4717093A AU4717093A (en) 1994-02-14
AU672810B2 true AU672810B2 (en) 1996-10-17

Family

ID=10719360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47170/93A Ceased AU672810B2 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds

Country Status (10)

Country Link
EP (1) EP0652864A1 (uk)
JP (1) JPH07509462A (uk)
AU (1) AU672810B2 (uk)
CA (1) CA2141214A1 (uk)
GB (1) GB9215921D0 (uk)
IL (1) IL106472A0 (uk)
MX (1) MX9304503A (uk)
TW (1) TW246670B (uk)
WO (1) WO1994002448A1 (uk)
ZA (1) ZA935378B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2104424T3 (es) * 1993-11-26 1997-10-01 Pfizer Compuestos de isoxazolina como agentes antiinflamatorios.
AU1326795A (en) * 1994-03-09 1995-09-25 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
WO1996023772A1 (fr) * 1995-02-02 1996-08-08 Nikken Chemicals Co., Ltd. Derives de n-hydroxyuree
CA2246265A1 (en) 1996-02-13 1997-08-21 G.D. Searle & Co. Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
EP0880363B1 (en) 1996-02-13 2002-09-11 G.D. SEARLE & CO. Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
CA2246356A1 (en) 1996-02-13 1997-08-21 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
NZ333441A (en) * 1996-06-25 1999-05-28 Cephalon Inc Use of k-252a derivatives for the treatment of peripheral or central nerve disorders, and cytokine overproduction
ES2189207T3 (es) * 1997-07-31 2003-07-01 Abbott Lab Inhibidores de hidroxamatos inversos de metaloproteinasas matriciales.
US6235786B1 (en) 1997-08-06 2001-05-22 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6294573B1 (en) 1997-08-06 2001-09-25 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6288261B1 (en) 1998-12-18 2001-09-11 Abbott Laboratories Inhibitors of matrix metalloproteinases
WO2000044712A1 (en) * 1999-01-27 2000-08-03 Abbott Laboratories N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
SE0103325D0 (sv) * 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
TW200946105A (en) 2008-02-07 2009-11-16 Kyorin Seiyaku Kk Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196184A2 (en) * 1985-03-16 1986-10-01 The Wellcome Foundation Limited Aryl derivatives
EP0299761A1 (en) * 1987-07-15 1989-01-18 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives
WO1992010469A1 (en) * 1990-12-11 1992-06-25 Pfizer Inc. Hydroxamic acid derivatives which inhibit lipoxygenase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0819069B2 (ja) * 1990-07-25 1996-02-28 アボツト・ラボラトリーズ リポキシゲナーゼ阻害活性を有するアセチレン誘導体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196184A2 (en) * 1985-03-16 1986-10-01 The Wellcome Foundation Limited Aryl derivatives
EP0299761A1 (en) * 1987-07-15 1989-01-18 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives
WO1992010469A1 (en) * 1990-12-11 1992-06-25 Pfizer Inc. Hydroxamic acid derivatives which inhibit lipoxygenase

Also Published As

Publication number Publication date
WO1994002448A1 (en) 1994-02-03
JPH07509462A (ja) 1995-10-19
GB9215921D0 (en) 1992-09-09
EP0652864A1 (en) 1995-05-17
ZA935378B (en) 1995-01-26
MX9304503A (es) 1994-04-29
IL106472A0 (en) 1993-11-15
CA2141214A1 (en) 1994-02-03
TW246670B (uk) 1995-05-01
AU4717093A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
AU672810B2 (en) Hydroxamic acid derivatives and their use as anti-inflammatory compounds
JP4036343B2 (ja) 疾患の治療のためのスルフォンアミド誘導体
US5155110A (en) Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
AU2011252337C1 (en) New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
US20050215590A1 (en) Formamide derivatives for the treatment of diseases
HU201300B (en) Process for production of derivatives of aryl and medical compositions containing them as active substance
US5731332A (en) Substituted benzamidine compounds which have useful pharmaceutical activity
EP0497564A1 (en) Benzamides
JP2007529499A (ja) β２受容体アゴニストとしてのフェニルアミノエタノール誘導体
EA011167B1 (ru) Производные сульфонамида для лечения заболеваний
JP2006526604A (ja) β−２アドレナリン受容体アゴニストとしての２−アミノ−ピリジン誘導体
US5686496A (en) Chemical compound, the preparation thereof and its use in pharmaceutical compositions
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
CZ277693B6 (en) Anti-atherosclerotic active compounds, pharmaceuticals containing such compounds and process for preparing thereof
JP2007529501A (ja) 疾患の治療のために有用な化合物
AP454A (en) Therapeutic compounds with hydroxamic acid derivatives.
WO1992009567A1 (en) Anti-inflammatory compounds
US5360909A (en) Phenoxyacetic acid compounds and medical preparations containing them
JP2661841B2 (ja) インドリン誘導体
JPH0662547B2 (ja) グリシン誘導体
JPH08509487A (ja) シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体
JP4033892B2 (ja) アドレナリン受容体として有用なホルムアミド誘導体
JP2001518473A (ja) 縮合ベンゾチオピラン化合物
WO1995002575A1 (en) 5-lipoxygenase inhibitors
MXPA06010629A (en) Phenylaminoethanol derivates as beta2 receptor agonists